Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease

Esta versión no es la más reciente

ver la versión actual 03 marzo 2020

Información

DOI:
https://doi.org/10.1002/14651858.CD012762Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 15 agosto 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Fibrosis quística y enfermedades genéticas

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Sudipta Pal

    Correspondencia a: Department of Community Medicine, Melaka‐Manipal Medical College, Melaka, Malaysia

    [email protected]

  • Ruchita Dixit

    Department of Community Medicine, Melaka‐Manipal Medical College, Melaka, Malaysia

  • Soe Moe

    Department of Community Medicine, Faculty of Medicine, Melaka, Malaysia

  • Myron A Godinho

    Public Health Evidence South Asia (PHESA), Manipal University, Manipal, India

  • Adinegara BL Abas

    Department of Community Medicine, Melaka‐Manipal Medical College, Melaka, Malaysia

  • Samir K Ballas

    Cardeza Foundation for Hematologic Research, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, USA

  • Shanker Ram

    Department of Psychiatry, Melaka Manipal Medical College, Melaka, Malaysia

  • Uduman Ali M Yousuf

    Department of Medicine, Melaka Manipal Medical College, Melaka, Malaysia

Contributions of authors

The following potential contributions of authors to each section of the review are described below.

·       Conceiving the review: Cochrane Cystic Fibrosis and Genetic Disorders Review Group

·       Designing the review: SP, RD, MG

·       Coordinating the review: SP, RD

. Writing the background, objectives and inclusion criteria sections: SP, MG

·       Data collection for the review: SP, MG

·       Designing search strategies: SP. ALA, SM, MG

·       Undertaking searches: SP, MG, SR

·       Screening search results: SP, MG

·       Organizing retrieval of papers: SP, MG, SM

·       Screening retrieved papers against eligibility criteria: SP, MG, UAY

·       Appraising quality of papers: SKB

·       Extracting data from papers: SP, SM

·       Writing to authors of papers for additional information: SP, MG

·       Providing additional data about papers: Cochrane Cystic Fibrosis and Genetic Disorders Review Group

·       Obtaining and screening data on unpublished studies: SP, MG

·       Data management for the review: SM, ALA

·       Entering data into RevMan: SP, SM, MG, ALA

·       Analysis of data: SP, SM, MG, ALA

·       Interpretation of data: SP, SM, MG, ALA

·       Providing a methodological perspective: ALA, SP

·       Providing a clinical perspective: SKB, UAY

·       Writing the review (or protocol): SP, MG

·       Providing general advice on the review: SKB, UAY

Sources of support

Internal sources

  • University of Liverpool,, UK.

External sources

  • The National Institute for Health Research (NIHR), UK.United Kingdom Cochrane Centre, UK.

Declarations of interest

All authors: none known.

Acknowledgements

We would like to thank:

Tracey Remmington, Managing Editor, Cochrane Cystic Fibrosis and Genetic Disorders Review Group for providing guidance in drafting the protocol;

Sarah Nevitt, Group Statistician, Cochrane Cystic Fibrosis and Genetic Disorders Review Group for providing guidance in drafting the protocol;

Natalie Hall, Information Specialist, Cochrane Cystic Fibrosis and Genetic Disorders Review Group, for comments on the search strategy.

We are very grateful to Professor Datuk Dr Abdul Razzak Chief Executive of Melaka‐Manipal Medical College, Malaysia and Professor Dr Jaspal Singh, Dean, Faculty of Medicine, Melaka‐Manipal Medical College, Malaysia for their constant support, constructive comments and encouragement in writing this protocol.

This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2020 Mar 03

Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease

Review

Sudipta Pal, Ruchita Dixit, Soe Moe, Myron Anthony Godinho, Adinegara BL Abas, Samir K Ballas, Shanker Ram, Uduman Ali M Yousuf

https://doi.org/10.1002/14651858.CD012762.pub2

2017 Aug 15

Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease

Protocol

Sudipta Pal, Ruchita Dixit, Soe Moe, Myron A Godinho, Adinegara BL Abas, Samir K Ballas, Shanker Ram, Uduman Ali M Yousuf

https://doi.org/10.1002/14651858.CD012762

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.